This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2023 Feb 28;81(8):e57-e58.

doi: 10.1016/j.jacc.2022.11.058.

Malignant Hypertensive Cardiomyopathy: Definition Matters

Romain Boulestreau, Philippe Gosse, Julien Doublet, Antoine Cremer

PMID: 36813381
DOI: 10.1016/j.jacc.2022.11.058

Free article

Comment

Malignant Hypertensive Cardiomyopathy: Definition Matters

Romain Boulestreau et al. J Am Coll Cardiol. 2023.

Free article

. 2023 Feb 28;81(8):e57-e58.

doi: 10.1016/j.jacc.2022.11.058.

Authors

Romain Boulestreau, Philippe Gosse, Julien Doublet, Antoine Cremer

PMID: 36813381
DOI: 10.1016/j.jacc.2022.11.058

No abstract available

PubMed Disclaimer

Comment in

Reply: Malignant Hypertensive Cardiomyopathy: Definition Matters.
Ascher SB, de Lemos JA, Lee M, Berry JD. Ascher SB, et al. J Am Coll Cardiol. 2023 Feb 28;81(8):e59. doi: 10.1016/j.jacc.2022.12.015. J Am Coll Cardiol. 2023. PMID: 36813382 No abstract available.

Comment on

Intensive Blood Pressure Lowering in Patients With Malignant Left Ventricular Hypertrophy.
Ascher SB, de Lemos JA, Lee M, Wu E, Soliman EZ, Neeland IJ, Kitzman DW, Ballantyne CM, Nambi V, Killeen AA, Ix JH, Shlipak MG, Berry JD. Ascher SB, et al. J Am Coll Cardiol. 2022 Oct 18;80(16):1516-1525. doi: 10.1016/j.jacc.2022.08.735. J Am Coll Cardiol. 2022. PMID: 36229087 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information